Annual report pursuant to Section 13 and 15(d)

Acquisitions, Investments, and Licenses (Details)

v2.4.0.6
Acquisitions, Investments, and Licenses (Details)
In Thousands, unless otherwise specified
Dec. 31, 2012
USD ($)
Dec. 31, 2011
USD ($)
Dec. 31, 2012
OURLab [Member]
USD ($)
Dec. 31, 2012
Farmadiet [Member]
USD ($)
Dec. 31, 2012
Farmadiet [Member]
EUR (€)
Dec. 31, 2012
ALS Acquisition [Member]
USD ($)
Apr. 30, 2012
ALS Acquisition [Member]
USD ($)
Summarizes the preliminary fair value of the net assets acquired and liabilities              
Current assets     $ 6,020 $ 8,367   $ 767  
Intangible assets:              
Customer relationships     3,860 436      
Technology     1,370 3,017      
In-process research and development       1,459      
Product registrations       2,930   2,300  
Licenses     70        
Covenants not to compete     6,900 187      
Tradename     1,830 349   680  
Total intangible assets     14,030 8,378   2,980  
Goodwill     29,629 8,062   458  
Property, plant and equipment     2,117 7,205   24  
Other assets     37 611      
Accounts payable and accrued expenses     (3,214) (3,438)   (229)  
Deferred tax liability     (6,356) (3,169)      
Debt assumed       (7,829)      
Contingent consideration (20,000) (100)          
Total purchase price $ 16,000   $ 42,263 $ 18,187 € 13,500 $ 4,000 $ 4,000